Insider · CIK 0001821315
Richard N. Grant Jr.
Files at INTT (INTEST CORP). First filing Mar 12, 2025, latest Mar 18, 2026.
Richard N. Grant Jr. files SEC Form 4 as CEO, president and director at INTT (INTEST CORP). Since Mar 12, 2025, Richard N. Grant Jr. has reported 0 open-market buys worth $0 and 3 open-market sells worth $87k, the latest filed on Mar 18, 2026.
A track record needs three past buys with six months of prices behind them; Richard N. Grant Jr. has 0, so none is measured yet.
The newest scored trade: sold $23k of INTT on Mar 18, 2026, filed Mar 18, 2026, scored 5 (weak), under a 10b5-1 plan. In the last 12 months: 0 buys worth $0 and 2 sells worth $58k.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
INTT: INTEST CORP
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 5Weak | INTEST CORP | $23k 1,636 shares | -1% | +150% from low-3% from high | |
| 11Weak | INTEST CORP | $34k 2,494 shares | -1% | +139% from low0% from high | |
| 10Weak | INTEST CORP | $29k 3,872 shares | -2% | - |
Planned sales
Form 144 notices this insider filed before selling restricted or control stock, newest first.
| Filed | Company | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| Mar 18, 2026 | INTT INTEST CORP | 1,636 0.01% of outstanding | $23k | Mar 18, 2026 | $34k |
Transactions
Every row this insider has filed, 21 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Mar 31, 2026 | INTT INTEST CORP | DDisposition to issuer Common Stock | -2,465 | $0.00 | $0 | 210,265 | Apr 2, 2026 |
| Mar 31, 2026 | INTT INTEST CORP | DDisposition to issuer Common Stock | -8,826 | $0.00 | $0 | 201,439 | Apr 2, 2026 |
| Mar 31, 2026 | INTT INTEST CORP | DDisposition to issuer Common Stock | -17,652 | $0.00 | $0 | 183,787 | Apr 2, 2026 |
| Mar 31, 2026 | INTT INTEST CORP | DDisposition to issuer Common Stock | -19,380 | $0.00 | $0 | 164,407 | Apr 2, 2026 |
| Mar 31, 2026 | INTT INTEST CORP | DDisposition to issuer Common Stock | -25,840 | $0.00 | $0 | 138,567 | Apr 2, 2026 |
| Mar 31, 2026 | INTT INTEST CORP | DDisposition to issuer Common Stock | -13,822 | $0.00 | $0 | 124,745 | Apr 2, 2026 |
| Mar 31, 2026 | INTT INTEST CORP | DDisposition to issuer Common Stock | -13,822 | $0.00 | $0 | 110,923 | Apr 2, 2026 |
| Mar 16, 2026 | INTT INTEST CORP | AGrant or award Common Stock10b5-1 | +13,822 | $0.00 | $0 | 200,544 | Mar 18, 2026 |
| Mar 16, 2026 | INTT INTEST CORP | AGrant or award Common Stock10b5-1 | +13,822 | $0.00 | $0 | 214,366 | Mar 18, 2026 |
| Mar 18, 2026 | INTT INTEST CORP | SOpen-market sale Common Stock10b5-1 | -1,636 | $14.28 | $23k | 212,730 | Mar 18, 2026 |
| Mar 16, 2026 | INTT INTEST CORP | AGrant or award Employee Stock Option (right to buy)derivative10b5-1 | +23,365 | $0.00 | $0 | 23,365 | Mar 18, 2026 |
| Mar 9, 2026 | INTT INTEST CORP | SOpen-market sale Common Stock10b5-1 | -1,097 | $13.33 | $15k | 188,119 | Mar 11, 2026 |
| Mar 11, 2026 | INTT INTEST CORP | SOpen-market sale Common Stock10b5-1 | -1,397 | $14.16 | $20k | 186,722 | Mar 11, 2026 |
| Mar 4, 2026 | INTT INTEST CORP | DDisposition to issuer Common Stock | -9,859 | $0.00 | $0 | 189,216 | Mar 5, 2026 |
| Apr 14, 2025 | INTT INTEST CORP | DDisposition to issuer Common Stock | -13,662 | $0.00 | $0 | 199,075 | Apr 14, 2025 |
| Mar 17, 2025 | INTT INTEST CORP | AGrant or award Common Stock | +25,840 | $0.00 | $0 | 186,897 | Mar 19, 2025 |
| Mar 17, 2025 | INTT INTEST CORP | AGrant or award Common Stock | +25,840 | $0.00 | $0 | 212,737 | Mar 19, 2025 |
| Mar 17, 2025 | INTT INTEST CORP | AGrant or award Employee Stock Option (right to buy)derivative | +2,327 | $4.61 | $11k | 2,327 | Mar 19, 2025 |
| Mar 17, 2025 | INTT INTEST CORP | AGrant or award Employee Stock Option (right to buy)derivative | +43,384 | $0.00 | $0 | 43,384 | Mar 19, 2025 |
| Mar 10, 2025 | INTT INTEST CORP | SOpen-market sale Common Stock10b5-1 | -2,688 | $7.48 | $20k | 162,241 | Mar 12, 2025 |
| Mar 11, 2025 | INTT INTEST CORP | SOpen-market sale Common Stock10b5-1 | -1,184 | $7.57 | $8,963 | 161,057 | Mar 12, 2025 |
Questions about Richard N. Grant Jr.
Answered from the filings on this page, as of the latest one.
Is Richard N. Grant Jr. buying or selling?
In the last 12 months Richard N. Grant Jr. reported 0 open-market buys worth $0 and 2 open-market sells worth $58k on SEC Form 4; the latest was sold $23k of INTT on Mar 18, 2026. Grants, option exercises and tax withholding are not counted.
How did Richard N. Grant Jr.'s past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Richard N. Grant Jr. has 0.
Where does Richard N. Grant Jr. file Form 4?
Richard N. Grant Jr. has filed Form 4 at INTT (INTEST CORP) as President & CEO. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.